Laurence Brugières

Active 1991–2024

129
Papers
18,249
Citations
76
h-index
122
i10-index

Citations

Citations per year for Laurence Brugières1992: 1 citations1995: 1 citations1996: 6 citations1997: 14 citations1998: 19 citations1999: 29 citations2000: 29 citations2001: 34 citations2002: 23 citations2003: 27 citations2004: 25 citations2005: 38 citations2006: 26 citations2007: 37 citations2008: 40 citations2009: 77 citations2010: 76 citations2011: 91 citations2012: 107 citations2013: 116 citations2014: 119 citations2015: 128 citations2016: 152 citations2017: 151 citations2018: 136 citations2019: 614 citations2020: 675 citations2021: 754 citations2022: 484 citations2023: 352 citations2024: 676 citations2025: 268 citations2026: 7 citations1993–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,619 citing papers, 20.6% of this breakdownFrance: 615 citing papers, 7.8% of this breakdownUnited Kingdom: 579 citing papers, 7.4% of this breakdownGermany: 556 citing papers, 7.1% of this breakdownItaly: 489 citing papers, 6.2% of this breakdownChina: 456 citing papers, 5.8% of this breakdownCanada: 343 citing papers, 4.4% of this breakdownNetherlands: 321 citing papers, 4.1% of this breakdownSpain: 245 citing papers, 3.1% of this breakdownAustralia: 216 citing papers, 2.8% of this breakdownSwitzerland: 198 citing papers, 2.5% of this breakdownJapan: 186 citing papers, 2.4% of this breakdown
0%20.6%Other 25.8%

Fields

  • Medicine68.1%
  • Biochemistry, Genetics and Molecular Biology24.6%
  • Immunology and Microbiology3.4%
  • Neuroscience2.1%
  • Engineering0.5%
  • Materials Science0.3%
  • Other1%

Topics

  • Neuroblastoma Research and Treatments4.2%
  • Sarcoma Diagnosis and Treatment3.9%
  • Lymphoma Diagnosis and Treatment3.5%
  • Cancer Genomics and Diagnostics3.4%
  • Cancer-related Molecular Pathways2.5%
  • Genetic factors in colorectal cancer2.5%
  • Other80%

Coauthors

All papers

Open in search
  1. Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 cited by 753

  2. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 369

  3. Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, A. Bassim Hassan, Stefanie Hecker‐Nolting, Peter Hohenberger, Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Leo Kager, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Ruth Ladenstein, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Bruce Morland, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Sandra J. Strauss, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, Winette T.A. van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 cited by 641

  4. Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2017 cited by 521

  5. Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , D. Zachar, Madeleine Joubert, Janick Sèlves, Dominique Pasquier, Paulette Bioulac‐Sage, Michael A. Grotzer, Margaret Childs, Monique Fabrè, Marie‐Annick Buendia - Cancer Cell 2008 cited by 509

  6. APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures

    Authors: , , , , , , , , , , , , , , , , , - OncoImmunology 2019 cited by 75

  7. Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood

    Authors: , , , , , , - Clinical Cancer Research 2017 cited by 221

  8. Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2017 cited by 145

  9. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Péter Hauser, Nada Jabado, Young‐Shin Ra, Karel Zitterbart, Suyash Shringarpure, Francisco M. De La Vega, Carlos D. Bustamante, Ho‐Keung Ng, Arie Perry, Tobey J. MacDonald, Pablo Hernáiz Driever, Anne Bendel, Daniel C. Bowers, Geoffrey McCowage, Murali Chintagumpala, Richard J. Cohn, Tim Hassall, Gudrun Fleischhack, Tone Eggen, Finn Wesenberg, Maria Feychting, Birgitta Lannering, Joachim Schüz, Christoffer Johansen, Tina Veje Andersen, Martin Röösli, Claudia E. Kuehni, Michael A. Grotzer, Kristina Kjærheim, Camelia Maria Monoranu, Tenley C. Archer, Elizabeth S. Duke, Scott L. Pomeroy, Shelagh Redmond, Stephan Frank, David Sumerauer, Wolfram Scheurlen, Marina Ryzhova, Till Milde, Christian P. Kratz, David Samuel, Jinghui Zhang, David A. Solomon, Marco A. Marra, Roland Eils, Claus R. Bartram, Katja von Hoff, Stefan Rutkowski, Vijay Ramaswamy, Richard J. Gilbertson, Andrey Korshunov, Michael D. Taylor, Peter Lichter, David Malkin, Amar Gajjar, Jan O. Korbel, Stefan M. Pfister - The Lancet Oncology 2018 cited by 394

  10. Germline Elongator mutations in Sonic Hedgehog medulloblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicholas G. Gottardo, Amy Smith, Christelle Dufour, Stefan Rutkowski, Tone Eggen, Finn Wesenberg, Kristina Kjærheim, Maria Feychting, Birgitta Lannering, Joachim Schüz, Christoffer Johansen, Tina Veje Andersen, Martin Röösli, Claudia E. Kuehni, Michael A. Grotzer, Marc Remke, Stéphanie Puget, Kristian W. Pajtler, Till Milde, Olaf Witt, Marina Ryzhova, Andrey Korshunov, Brent A. Orr, David W. Ellison, Laurence Brugières, Peter Lichter, Kim E. Nichols, Amar Gajjar, Brandon J. Wainwright, Olivier Ayrault, Jan O. Korbel, Paul A. Northcott, Stefan M. Pfister - Nature 2020 cited by 171

  11. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘Care for CMMRD’ (C4CMMRD)

    Authors: , , , , , , , , , , , , , , , - Journal of Medical Genetics 2014 cited by 474

  12. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2013 cited by 339

  13. CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , - OncoImmunology 2017 cited by 170

  14. BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marion Gillibert‐Yvert, Jean‐Louis Stéphan, Fleur Cohen‐Aubart, Julien Haroche, Isabelle Pellier, Frédéric Millot, Brigitte Lescoeur, Virginie Gandemer, Christine Bodemer, Roger Lacave, Zofia Hélias‐Rodzewicz, Valérie Taly, Frédéric Geissmann, Jean Donadieu - Journal of Clinical Oncology 2016 cited by 335

  15. Diagnostic criteria for constitutional mismatch repair deficiency (CMMRD): recommendations from the international consensus working group

    Authors: , , , , , , , , , , , , , - Journal of Medical Genetics 2021 cited by 142

  16. Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2024 cited by 38

  17. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

    Authors: , , , , , , , , , , , , , , , - Nature 2008 cited by 898

  18. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sophie Gad, Stéphane Richard, Jérôme Couturier, Bin Tean Teh, Paola Ghiorzo, Lorenza Pastorino, Susana Puig, Célia Bádenas, Håkan Olsson, Christian Ingvar, Etienne Rouleau, Rosette Lidereau, Philippe Bahadoran, Philippe Vielh, Eve Corda, Hélène Blanché, Diana Zélénika, Pilar Galán, The French Familial Melanoma Study Group, F. Aubin, Bertrand Bachollet, Céline Becuwe, Pascaline Berthet, Yves Jean Bignon, Valérie Bonadona, Jean‐Louis Bonafé, Marie‐Noëlle Bonnet‐Dupeyron, F. Cambazard, J. Chevrant‐Breton, Isabelle Coupier, S. Dalac, Liliane Demange, M. D’Incan, Catherine Dugast, Laurence Faivre, Lynda Vincent-Fétita, Marion Gauthier-Villars, Brigitte Gilbert, Florent Grange, Jean‐Jacques Grob, Philippe Humbert, Nicolas Janin, Pascal Joly, Delphine Kérob, Christine Lasset, Dominique Leroux, J. Levang, Jean‐Marc Limacher, C. Bulaï Livideanu, Michel Longy, Alain Lortholary, Dominique Stoppa-Lyonnet, Sandrine Mansard, L Mansuy, Karine Marrou, Christine Matéus, Christine Maugard, Nicolás Meyer, Catherine Noguès, P Souteyrand, Laurence Venat‐Bouvet, Hélène Zattara, Valérie Chaudru, Gilbert Lenoir, Mark Lathrop, Irwin Davidson, Marie-Françoise Avril, Florence Démenais, Robert Ballotti, Brigitte Bressac–de Paillerets - Nature 2011 cited by 522

  19. Predisposition to cancer in children and adolescents

    Authors: , , , , , , , , , , , , , , , - The Lancet Child & Adolescent Health 2021 cited by 123

  20. Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma

    Authors: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 322

  21. New insights into diagnosis and therapeutic options for proliferative hepatoblastoma

    Authors: , , , , , , , , , , , , , , , , , , , - Hepatology 2017 cited by 153

  22. Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Acta Obstetricia Et Gynecologica Scandinavica 2019 cited by 102

  23. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 cited by 210

  24. Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Medical Genetics 2017 cited by 118